{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:12:37Z","timestamp":1783113157102,"version":"3.54.6"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.mehy.2006.10.015","type":"journal-article","created":{"date-parts":[[2006,12,6]],"date-time":"2006-12-06T12:13:37Z","timestamp":1165407217000},"page":"979-987","source":"Crossref","is-referenced-by-count":30,"title":["Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders"],"prefix":"10.1016","volume":"68","author":[{"given":"James Jeffrey","family":"Bradstreet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Granpeesheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"El-Dahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2006.10.015_bib1","first-page":"217","article-title":"Autistic disturbances of affective contact","volume":"2","author":"Kanner","year":"1943","journal-title":"Nervous Child"},{"issue":"7413","key":"10.1016\/j.mehy.2006.10.015_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bmj.327.7413.488","article-title":"Diagnosis of autism","volume":"327","author":"Baird","year":"2003","journal-title":"BMJ"},{"issue":"9531","key":"10.1016\/j.mehy.2006.10.015_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(06)69041-7","article-title":"Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)","volume":"368","author":"Baird","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2006.10.015_bib4","unstructured":"Schieve LA, Rice C, Boyle C, Visser SN, Blumberg SJ. Mental Health in the United States: Parental Report of Diagnosed Autism in Children Aged 4\u201317 Years \u2013 United States, 2003\u20132004. Morbidity and Mortality Weekly Report 2006;55(17):481\u20136."},{"issue":"11","key":"10.1016\/j.mehy.2006.10.015_bib5","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1176\/ajp.154.11.1626-a","article-title":"Androgenic activity in autism","volume":"154","author":"Tordjman","year":"1997","journal-title":"Am J Psychiatr"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.015_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1469-7610.2004.00349.x","article-title":"Foetal testosterone, social relationships, and restricted interests in children","volume":"46","author":"Knickmeyer","year":"2005","journal-title":"J Child Psychol Psychiatr"},{"issue":"4","key":"10.1016\/j.mehy.2006.10.015_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000094467","article-title":"A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders","volume":"66","author":"Geier","year":"2006","journal-title":"Horm Res"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF01543467","article-title":"Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination","volume":"6","author":"Stubbs","year":"1976","journal-title":"J Autism Child Schizophr"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.015_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01531114","article-title":"Depressed lymphocyte responsiveness in autistic children","volume":"7","author":"Stubbs","year":"1977","journal-title":"J Autism Child Schizophr"},{"issue":"11","key":"10.1016\/j.mehy.2006.10.015_bib10","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1176\/ajp.139.11.1462","article-title":"Abnormal immune response to brain tissue antigen in the syndrome of autism","volume":"139","author":"Weizman","year":"1982","journal-title":"Am J Psychiatr"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.015_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01531729","article-title":"Immune abnormalities in patients with autism","volume":"16","author":"Warren","year":"1986","journal-title":"J Autism Dev Disord"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004583-198705000-00008","article-title":"Reduced natural killer cell activity in autism","volume":"26","author":"Warren","year":"1987","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib13","first-page":"339","article-title":"Immune status in infantile autism. Correlation between the immune status, autistic symptoms and levels of serotonin [French]","volume":"14","author":"Ferrari","year":"1988","journal-title":"Encephale"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08820139009041839","article-title":"Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism","volume":"19","author":"Warren","year":"1990","journal-title":"Immunol Invest"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.015_bib15","first-page":"75","article-title":"Psychoimmunology. II. The neuroendocrine system and the immune system in autism and schizophrenia [Italian]","volume":"32","author":"Francesetti","year":"1991","journal-title":"Minerva Psychiatr"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0090-1229(05)80015-7","article-title":"Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children","volume":"61","author":"Singh","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.015_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000119172","article-title":"DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein","volume":"31","author":"Warren","year":"1995","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib18","first-page":"351","article-title":"Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone","volume":"32","author":"Scifo","year":"1996","journal-title":"Ann Ist Super Sanita"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.015_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0887-8994(97)00045-3","article-title":"Circulating autoantibodies to neuronal and glial filament protein in autism","volume":"17","author":"Singh","year":"1997","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.015_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(97)00976-2","article-title":"Urinary levels of neopterin and biopterin in autism","volume":"241","author":"Messahel","year":"1998","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3476(99)70248-9","article-title":"Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders","volume":"134","author":"Connolly","year":"1999","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.mehy.2006.10.015_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.biopsych.2005.07.004","article-title":"Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy","volume":"59","author":"Connolly","year":"2006","journal-title":"Biol Psychiatr"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2006.10.015_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jneuroim.2005.11.007","article-title":"Elevated cytokine levels in children with autism spectrum disorder","volume":"172","author":"Molloy","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2006.10.015_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0165-5728(01)00421-0","article-title":"Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression","volume":"120","author":"Jyonouchi","year":"2001","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.015_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000084164","article-title":"Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention","volume":"51","author":"Jyonouchi","year":"2005","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10284150400004155","article-title":"Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism","volume":"7","author":"Vojdani","year":"2004","journal-title":"Nutr Neurosci"},{"issue":"9103","key":"10.1016\/j.mehy.2006.10.015_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","article-title":"Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"351","author":"Wakefield","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0022-3476(99)70052-1","article-title":"Gastrointestinal abnormalities in children with autistic disorder","volume":"135","author":"Horvath","year":"1999","journal-title":"J Pediatr"},{"issue":"9411","key":"10.1016\/j.mehy.2006.10.015_bib29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(04)15715-2","article-title":"Retraction of an interpretation","volume":"363","author":"Murch","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.mehy.2006.10.015_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1572-0241.2005.41202_4.x","article-title":"Panenteric IBD-like disease in a patient with regressive autism shown for the first time by the wireless capsule enteroscopy: another piece in the jigsaw of this gut-brain syndrome?","volume":"100","author":"Balzola","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mehy.2006.10.015_bib31","unstructured":"Chauhan A, Mehta PD, Cohen IL, Barshatzky M, Brown T, Chauhan V. Increased serum complement C3\/C4 and alpha-1-antichymotrypsin levels in autism. PS3.19, IMFAR. http:\/\/conferences.ucdavis.edu\/imfar\/IMFAR_2006_abstract_book.pdf. June, 2006 [accessed 10\/2\/06]."},{"key":"10.1016\/j.mehy.2006.10.015_bib32","unstructured":"Gillberg C. Autism spectrum conditions: what are the associated problems and what can they tell us? IMFAR. http:\/\/conferences.ucdavis.edu\/imfar\/IMFAR_2006_abstract_book.pdf. June, 2006 [accessed 10\/2\/06]."},{"issue":"6","key":"10.1016\/j.mehy.2006.10.015_bib33","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s10875-004-6241-6","article-title":"Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory Interleukin-10","volume":"24","author":"Ashwood","year":"2004","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.015_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pediatrneurol.2005.03.014","article-title":"Cerebrospinal fluid and serum markers of inflammation in autism","volume":"33","author":"Zimmerman","year":"2005","journal-title":"Pediatr Neurol"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2006.10.015_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jneuroim.2006.05.025","article-title":"Antibrain antibodies in children with autism and their unaffected siblings","volume":"178","author":"Singer","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.mehy.2006.10.015_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF02172828","article-title":"Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics","volume":"26","author":"Gupta","year":"1996","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.mehy.2006.10.015_bib38","unstructured":"Oleske J. Another view of autism. UMDNJ Research 2004;5(1):22-23. http:\/\/www.umdnj.edu\/research\/publications\/winter_04.pdf. [accessed 10\/2\/06]."},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01539635","article-title":"Disruptive behavior: a dietary approach","volume":"8","author":"O\u2019Banion","year":"1978","journal-title":"J Autism Child Schizophr"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib40","first-page":"137","article-title":"Food allergy and infantile autism","volume":"37","author":"Lucarelli","year":"1995","journal-title":"Panminerva Med"},{"key":"10.1016\/j.mehy.2006.10.015_bib41","first-page":"57","article-title":"Autism and schizophrenia: intestinal disorders","volume":"2","author":"Cade","year":"1999","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.mehy.2006.10.015_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/0031383950390304","article-title":"Autistic syndromes and diet: a four year follow-up study","volume":"39","author":"Knivbserg","year":"1995","journal-title":"Scand J Educat Res"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1005568027292","article-title":"Immunological treatments for autism","volume":"30","author":"Gupta","year":"2000","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1067\/mpd.2000.105355","article-title":"Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome","volume":"136","author":"Shenoy","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.mehy.2006.10.015_bib45","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00004583-199508000-00022","article-title":"Case study: corticosteroid treatment of language regression in pervasive developmental disorder","volume":"34","author":"Stefanatos","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"key":"10.1016\/j.mehy.2006.10.015_bib46","series-title":"New developments in child neurology","first-page":"695","article-title":"Practical treatment with pulse dose corticosteroids in pervasive developmental disorder or autistic patients with abnormal epileptiform sleep EEG and language delay","author":"Chez","year":"1998"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib47","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.mehy.2004.11.018","article-title":"The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity","volume":"64","author":"Geier","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2006.10.015_bib48","unstructured":"Geier M, Geier D. The biochemical basis for the treatment of autistic disorders: the androgen (Testosterone) \u2013 glutathione connection. http:\/\/www.autismone.org\/download2006.cfm. May, 2006 [accessed 10\/2\/06]."},{"issue":"2","key":"10.1016\/j.mehy.2006.10.015_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1023088526314","article-title":"Sexual behaviors in autism: problems of definition and management","volume":"29","author":"Realmuto","year":"1999","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1345\/aph.1E618","article-title":"Clinical experience with spironolactone in pediatrics","volume":"39","author":"Buck","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.mehy.2006.10.015_bib51","unstructured":"Package Label for Aldactone\u00ae Pfizer Inc. http:\/\/www.pfizer.com\/pfizer\/download\/uspi_aldactone.pdf [accessed 10\/2\/06]."},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib52","first-page":"641","article-title":"Effects in animals of chronic administration of spironolactone \u2013 a review","volume":"1","author":"Lumb","year":"1978","journal-title":"J Environ Pathol Toxicol"},{"key":"10.1016\/j.mehy.2006.10.015_bib53","first-page":"829","article-title":"Effect of aldactone, an antiminera-locorticoid steroid spironolactone, on inflammation","volume":"20","author":"Bajusz","year":"1961","journal-title":"Rev Can Biol"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1254\/jphs.SC0060049","article-title":"Anti-inflammatory effect of spironolactone on human peripheral blood mononuclear cells","volume":"101","author":"Miura","year":"2006","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.015_bib55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2249.2003.02249.x","article-title":"The Spironolactone\/Arthritis Study Group. Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis","volume":"134","author":"Bendtzen","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.mehy.2006.10.015_bib56","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/jc.2005-1718","article-title":"Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy","volume":"91","author":"Takebayashi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mehy.2006.10.015_bib57","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","article-title":"Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism","volume":"80","author":"James","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mehy.2006.10.015_bib58","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","volume":"4","author":"Farquhar","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.015_bib59","first-page":"115","article-title":"Topical spironolactone inhibits dihydrotestosterone receptors in human sebaceous glands: an autoradiographic study in subjects with acne vulgaris","volume":"10","author":"Berardesca","year":"1988","journal-title":"Int J Tissue React"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib60","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1530\/eje.0.1350604","article-title":"Spironolactone therapy in hypertrichosis","volume":"135","author":"Darendeliler","year":"1996","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.015_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jc.84.1.175","article-title":"Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset","volume":"84","author":"Leschek","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib62","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1517\/13543784.10.5.943","article-title":"The spironolactone renaissance","volume":"10","author":"Doggrell","year":"2001","journal-title":"Expert Opin Inv Drug"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.015_bib63","first-page":"492","article-title":"Psychometric characteristics of the aberrant behavior checklist","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Def"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.015_bib64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1044\/1058-0360(2003\/080)","article-title":"The relationship between standardized measures of language and measures of spontaneous speech in children with autism","volume":"12","author":"Condouris","year":"2003","journal-title":"Am J Speech Lang Pathol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987706007535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987706007535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T18:50:21Z","timestamp":1555959021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987706007535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0306987706007535"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2006.10.015","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}